Do you recommend testing for UGT1A1 prior to initiating sacituzimab govitecan for patients with metastatic TNBC to mitigate neutropenia risk?  


Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution